Q
QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

25,525 signal articles · 28 in last 24h · 122,300 total before filter · latest 1h ago
28last 24h
1250last 7d
210● bullish (7d)
151● bearish (7d)
205publishers
AllMacro210Earnings429M&A97Regulatory24Product9Analyst11
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Oracle (ORCL) Lands Joint Ontario Hospital EHR Rollout With Baycrest And Sunnybrook
Simply Wall St.19d agoneutral
Oracle (ORCL) Lands Joint Ontario Hospital EHR Rollout With Baycrest And Sunnybrook

Baycrest Hospital and Sunnybrook Health Sciences Centre are rolling out a joint Oracle Health EHR platform across hospital and ambulatory clinics in Ontario. The project focuses on improving care coordination, clinician workflow, and patient experiences across multi facility health systems. This customer win expands Oracle Health’s presence in mission critical healthcare IT and supports digitization of clinical operations. For investors tracking NYSE:ORCL, this move underlines Oracle’s push...

MT Newswires19d agoneutral
Top Midday Decliners

Sportradar (SRAD) shares sank 16% amid heavy trading after the company reported Monday that it swung

Johnson & Johnson (JNJ) Gets FDA Nod For OTTAVA As It Enters Surgical Robotics
Simply Wall St.19d agoneutral
Johnson & Johnson (JNJ) Gets FDA Nod For OTTAVA As It Enters Surgical Robotics

Johnson & Johnson (NYSE:JNJ) received FDA authorization for its OTTAVA robotic surgical system. The company is moving ahead with the commercial launch of OTTAVA as its first table integrated, soft tissue robotic platform. This marks Johnson & Johnson's entry into the competitive surgical robotics market with a differentiated system design. For investors watching Johnson & Johnson, the OTTAVA approval adds a new dimension to the MedTech story. Surgical robotics has become a focus area for...

Visa’s Latest Deal Signals New Era in Fighting Digital Scams
Barrons.com19d agoneutral
Visa’s Latest Deal Signals New Era in Fighting Digital Scams

Visa’s latest deal could signal a new era in fighting digital scams as artificial intelligence-enabled fraud spreads. The payments giant plans to buy BioCatch, a provider of fraud intelligence technology, for $2.4 billion in cash. Visa said the addition of BioCatch will complement its current security efforts and help clients better protect themselves and their customers from the growing threat of account takeovers, scams, money mules, and application fraud.

US regulators grant long-awaited Boeing 737 MAX 7 certificate
AFP19d agoneutral
US regulators grant long-awaited Boeing 737 MAX 7 certificate

More than eight years after Boeing organized the maiden flight of the 737 MAX 7, the aircraft has won certification, US authorities announced Monday.Monday's announcement marks Boeing's first new aircraft certified since the safety problems that have engulfed the company in recent years.

3 ETFs Surging as Amazon Clears $3 Trillion Market Cap
24/7 Wall St.19d agoneutral
3 ETFs Surging as Amazon Clears $3 Trillion Market Cap

Amazon just handed investors a historic earnings blowout, and three ETFs built on top of the stock are racing higher in completely different directions. Which one you held this week made all the difference.